FOXD1 and nasopharyngeal carcinoma: Importantly, FOXD1 can transcriptionally activate BNIP3 expression, leading to BNIP3-mediated mitophagy and ultimately promoting NPC cell growth, migration, invasion, and insensitivity to chemotherapeutic drugs.